EUVIMEDEUVIMED entdecken
Open Access

A Bayesian framework to study tumor subclone–specific expression by combining bulk DNA and single-cell RNA sequencing data

Yi Qiao iD, Xiaomeng Huang, Philip J Moos, Jonathan M Ahmann, Anthony D Pomicter, Michael W Deininger, John C Byrd, Jennifer A Woyach, Deborah M Stephens iD, Gabor T Marth

Genome Research · 2024

DOI: 10.1101/gr.278234.123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genome Research, 2024. Verfasst von Yi Qiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah 84112, USA. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic and gene expression heterogeneity is an essential hallmark of many tumors, allowing the cancer to evolve and to develop resistance to treatment. Currently, the most commonly used data types for studying such heterogeneity are bulk tumor/normal whole-genome or whole-exome sequencing (WGS, WES); and single-cell RNA sequencing (scRNA-seq), respectively. However, tools are currently lacking to link genomic tumor subclonality with transcriptomic heterogeneity by integrating genomic and single-cell transcriptomic data collected from the same tumor. To address this gap, we developed scBayes, a Bayesian probabilistic framework that uses tumor subclonal structure inferred from bulk DNA sequencing data to determine the subclonal identity of cells from single-cell gene expression (scRNA-seq) measurements. Grouping together cells representing the same genetically defined tumor subclones allows comparison of gene expression across different subclones, or investigation of gene expression changes within the same subclone across time (i.e., progression, treatment response, or relapse) or space (i.e., at multiple metastatic sites and organs). We used simulated data sets, in silico synthetic data sets, as well as biological data sets generated from cancer samples to extensively characterize and validate the performance of our method, as well as to show improvements over existing methods. We show the validity and utility of our approach by applying it to published data sets and recapitulating the findings, as well as arriving at novel insights into cancer subclonal expression behavior in our own data sets. We further show that our method is applicable to a wide range of single-cell sequencing technologies including single-cell DNA sequencing as well as Smart-seq and 10x Genomics scRNA-seq protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansExome SequencingBayes TheoremGene Expression ProfilingSequence Analysis, RNASingle-Cell Analysis

Autor:innen und Institutionen

  • Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah 84112, USA.
  • Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah 84112, USA.
  • Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA.
  • Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, Utah 84112, USA.
  • The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA.
  • Eccles Institute of Human Genetics, University of Utah, Salt Lake City, Utah 84112, USA; gabor.marth@gmail.com gmarth@genetics.utah.edu.

ORCID-Profile: Yi Qiao, Deborah M Stephens

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Utah Genome Project
  • The V Foundation for Cancer Research
  • National Cancer Institute

Zitieren

APA

Qiao, Y., Huang, X., Moos, P. J., Ahmann, J. M., Pomicter, A. D., Deininger, M. W., Byrd, J. C., Woyach, J. A., Stephens, D. M., & Marth, G. T. (2024). A Bayesian framework to study tumor subclone–specific expression by combining bulk DNA and single-cell RNA sequencing data. Genome Research. https://doi.org/10.1101/gr.278234.123

Vancouver

Qiao Y, Huang X, Moos PJ, Ahmann JM, Pomicter AD, Deininger MW, et al. A Bayesian framework to study tumor subclone–specific expression by combining bulk DNA and single-cell RNA sequencing data. Genome Research. 2024. doi:10.1101/gr.278234.123

BibTeX
@article{Qiao2024,
  author = {Qiao, Yi and Huang, Xiaomeng and Moos, Philip J and Ahmann, Jonathan M and Pomicter, Anthony D and Deininger, Michael W and Byrd, John C and Woyach, Jennifer A and Stephens, Deborah M and Marth, Gabor T},
  title = {A Bayesian framework to study tumor subclone–specific expression by combining bulk DNA and single-cell RNA sequencing data},
  journal = {Genome Research},
  year = {2024},
  doi = {10.1101/gr.278234.123}
}
Kostenlos starten →